Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis.
Mice with targeted deletion of STAT3 in CD4(+) T-cells do not develop experimental autoimmune uveitis (EAU) or experimental autoimmune encephalomyelitis (EAE), in part, because they cannot generate pathogenic Th17 cells. In this study, we have used ORLL-NIH001, a small synthetic compound that inhibi...
Saved in:
Main Authors: | Cheng-Rong Yu, Yun Sang Lee, Rashid M Mahdi, Narayanan Surendran, Charles E Egwuagu |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/fbd6e81b7dbb4f49ab2ddea188fe7c74 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
by: Cheng-bo Fang, et al.
Published: (2013) -
Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
by: Paul M. Panipinto, et al.
Published: (2021) -
Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis
by: Lingling Bai, et al.
Published: (2017) -
NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis
by: Wei Lin, et al.
Published: (2017) -
No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis.
by: María Carmen Cénit, et al.
Published: (2013)